Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 류형수, 임혜정filedCritical류형수
Priority to KR1019930005122ApriorityCriticalpatent/KR940021082A/en
Publication of KR940021082ApublicationCriticalpatent/KR940021082A/en
본 발명은 생체조직보전재생조성물에 관한 것으로, 약용성분의 유효성분을 경피적으로 인체에 침투 흡수시키기 위한 새로운 조성물 및 드럭델 리버리 시스템(drug delivery system : D.D.S.)을 제공하는데 목적이 있으며, 특히 콜라겐, 요소 등의 폴리펩티드 및 키토산등을 함유하는 크림상 조성물에 아스코르빈산등의 필요한 기능성 성분을 배합한 것을 사용하므로써 본래의 생체조직과 일체화된 인공적인 생체조직을 형성하여 재생시켜 주므로써 인공생체조직으로도 이용 가능한 효과가 있다.The present invention relates to a tissue tissue regeneration composition, the object of the present invention is to provide a novel composition and drug delivery system (DDS) for percutaneously absorbing and absorbing the active ingredient of the medicinal ingredients, especially collagen By combining the necessary functional ingredients such as ascorbic acid with a creamy composition containing polypeptides such as urea, chitosan and the like, artificial biological tissue is formed by regenerating artificial biological tissue integrated with the original biological tissue. There is also an effect available.
Description
생체조직보전형조성물Biotissue Integrity Composition
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음Since this is an open matter, no full text was included.
Claims (2)
콜라겐, 요소등의 폴리펩티드, 키토산 및 기능성 성분으로 구성됨을 특징으로 하는 생체조직보전형성 조성물.A biotissue integrity-forming composition comprising collagen, polypeptides such as urea, chitosan, and functional ingredients.제1항에 있어서, 기능성 성분으로는 아스코르빈산을 함유시키는 것을 특징으로 하는 생체조직보전형성 조성물.The composition of claim 1, wherein the functional component contains ascorbic acid.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.※ Note: The disclosure is based on the initial application.
PROCESS FOR THE PREPARATION OF ANTICOAGULANT PHARMACEUTICAL COMPOSITIONS CONTAINING AS ACTIVE INGREDIENT PROTEIN C OR PROTEIN C ACTIVATED COMBINED WITH HEPARIN
PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING DIHYDROXY-1,8PHENYL-10 ANTRONE-9 AS THE ACTIVE INGREDIENT, AND PROCEDURE FOR PREPARATION OF THE ACTIVE INGREDIENT.